The US Food and Drug Administration on Monday announced the approval of a drug called ubrogepant for the acute treatment of migraine, which could be a new option for people who can't take or don't respond to migraine medications currently on the market.
from CNN.com - RSS Channel - App International Edition https://ift.tt/3728sWh
Subscribe to:
Post Comments (Atom)
England win series v NZ after rain ruins third T20
England's third T20 against New Zealand is washed out by rain in Auckland, giving Harry Brook's side a 1-0 series victory. from BB...
-
President Donald Trump's phone calls with his lawyer Rudy Giuliani are sparking concerns about whether hostile foreign countries are lis...
-
North Korean leader Kim Jong Un had nothing but praise for "the compatriots in the south" at the start of 2019, speaking of "...
-
Robots are the intrepid explorers of our solar system, boldly venturing where humans can't to capture images and scientific data about o...
No comments:
Post a Comment